Chinese pharmaceutical companies’ hopes of selling their products abroad have received a boost after China’s drug regulator was accepted as a member of an international organization that focuses on standardizing global drug regulations.
Chinesepharmaceuticalcompanies’hopesofsellingtheirproductsabroadhavereceivedaboostafterChina’sdrugregulatorwasacceptedasamemberofaninternationalorganizationthat
简体中文
